Regulation - Gilead Sciences, Markets & Marketing

Filter

Popular Filters

Actavis confirms generic Exelon Patch patent challenge; InnoPharma debuts generic Vistide in USA

09-03-2013

US generics drugmaker Actavis (NYSE: ACT, formerly trading as Watson) confirmed that it has filed with…

ActavisAnti-viralsExelon PatchGenericsGilead SciencesInnoPharmaMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaNovartisPatentsRegulationVistide

Back to top